In a move to shift the battle against chronic pain and opioid addiction, U.S. Senator Maria Cantwell (D-WA) has stepped up alongside Senator Steve Daines (R-MT) to introduce the Relief of Chronic Pain Act, an initiative that pushes Medicare to cover non-opioid pain management treatments. The aim is to alleviate the dependence on opioids that has led to a surge in overdoses across the country, notably accounting for over 60% in Washington state over the last twenty years. "This bill will allow seniors to access non-opioid pain management options to treat chronic pain and help with longer term recoveries," Cantwell said in a statement.
The urgency of Cantwell's legislative push is punctuated by a stark reality: one in five adults in the U.S. is grappling with chronic pain, and nearly half of the 50 million sufferers experience acute restrictions that impact daily life and productivity. Medicare beneficiaries have been pinned at the epicenter of the opioid crisis, with one of the highest and most rapidly increasing rates of diagnosed opioid use disorder. The bill proposes significant changes to Medicare Part D, including waiving deductibles for non-opioid drugs, placing them in a low-cost tier, and barring certain administrative hurdles like step therapy and prior authorization.
Senator Cantwell's dedication to this cause is woven through her extensive efforts to meet with Washington constituents affected by the opioid crisis and her legislative initiatives. She has spearheaded numerous bills aimed at curbing the epidemic, which include expanding treatment programs, enhancing overdose data collection, tightening regulations around illicit synthetic drug trafficking, and more. Her outreach has spanned a significant stretch of her home state, gathering insights from varied demographics such as first responders, healthcare providers, law enforcement, and tribal leaders.
Among her legislative achievements, Cantwell has been instrumental in the enactment of laws addressing the opioid crisis, such as The Halt All Lethal Trafficking of Fentanyl Act under President Trump and The FEND Off Fentanyl Act under President Biden, to name a few, which reflects a bipartisan recognition of the opioid epidemic's severity. Her legislative portfolio also reveals an astute understanding of the broader aspects of substance abuse, engaging issues like the illegal trafficking of synthetic drugs, the management of controlled substances in veterinary practices, and the support of tribal law enforcement agencies.
This recent legislative initiative underscores the ongoing and nonpartisan effort to bring to the fold a wider array of treatments for chronic pain, acknowledging the complexities of addiction while endeavoring to provide more secure healthcare options for millions of Americans. Cantwell's work demonstrates a continued commitment to confronting a crisis that unwaveringly grips at the wellbeing of citizens across the nation.
_(46388010925).jpg){kind=link}